169 related articles for article (PubMed ID: 32685895)
1. Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism.
Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
Res Pract Thromb Haemost; 2020 Jul; 4(5):860-865. PubMed ID: 32685895
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage.
de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P
Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398
[TBL] [Abstract][Full Text] [Related]
3. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
Zwicker JI; Karp Leaf R; Carrier M
J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
[TBL] [Abstract][Full Text] [Related]
5. Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage.
Nguyen T; Sharma M; Crooks P; Patel PV; Bonow RH; Creutzfeldt CJ; Wahlster S
Br J Neurosurg; 2022 Apr; 36(2):251-257. PubMed ID: 35343356
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review.
Gorman J; Candeloro M; Schulman S
Thromb Haemost; 2023 Oct; 123(10):966-975. PubMed ID: 37015326
[TBL] [Abstract][Full Text] [Related]
7. Intracranial hemorrhage in setting of glioblastoma with venous thromboembolism.
Khoury MN; Missios S; Edwin N; Sakruti S; Barnett G; Stevens G; Peereboom DM; Khorana AA; Ahluwalia MS
Neurooncol Pract; 2016 Jun; 3(2):87-96. PubMed ID: 31386010
[TBL] [Abstract][Full Text] [Related]
8. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.
Reed-Guy L; Desai AS; Phillips RE; Croteau D; Albright K; O'Neill M; Brem S; O'Rourke DM; Amankulor NM; Bagley SJ
Neuro Oncol; 2022 Dec; 24(12):2172-2179. PubMed ID: 35551405
[TBL] [Abstract][Full Text] [Related]
9. The Dilemma of Resuming Antithrombotic Therapy After Intracranial Hemorrhage in Patients With Left Ventricular Assist Devices.
Santos CD; Matos NL; Asleh R; Dawit S; Rabinstein AA; O'Carroll CB; Li Z; Freeman WD
Neurocrit Care; 2020 Jun; 32(3):822-827. PubMed ID: 31531758
[TBL] [Abstract][Full Text] [Related]
10. Challenges in anticoagulation for patients with brain tumors.
Iyengar V; Patell R; Zwicker J
Best Pract Res Clin Haematol; 2022 Mar; 35(1):101350. PubMed ID: 36030073
[TBL] [Abstract][Full Text] [Related]
11. Venous Thromboembolism in ICU Patients with Intracerebral Hemorrhage: Risk Factors and the Prognosis After Anticoagulation Therapy.
Chu Q; Liao L; Wei W; Ye Z; Zeng L; Qin C; Tang Y
Int J Gen Med; 2021; 14():5397-5404. PubMed ID: 34526808
[TBL] [Abstract][Full Text] [Related]
12. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Rojas-Hernandez CM; Oo TH; García-Perdomo HA
J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
[TBL] [Abstract][Full Text] [Related]
13. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
Witt DM; Clark NP; Martinez K; Schroeder A; Garcia D; Crowther MA; Ageno W; Dentali F; Ye X; Hylek E; Delate T
Thromb Res; 2015 Nov; 136(5):1040-4. PubMed ID: 26454758
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs.
Poli D; Antonucci E; Vignini E; Martinese L; Testa S; Simioni P; Pengo V; Pignatelli P; Falanga A; Masciocco L; Barcellona D; Ciampa A; Chiarugi P; Paparo C; Ageno W; Palareti G;
Eur J Intern Med; 2020 Oct; 80():73-77. PubMed ID: 32522446
[TBL] [Abstract][Full Text] [Related]
15. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R
Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875
[TBL] [Abstract][Full Text] [Related]
16. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
Nielsen PB; Larsen TB; Skjøth F; Lip GY
JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
[TBL] [Abstract][Full Text] [Related]
17. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
Jo J; Donahue J; Sarai G; Petroni G; Schiff D
Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073
[TBL] [Abstract][Full Text] [Related]
18. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
Robertson L; Yeoh SE; Ramli A
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
[TBL] [Abstract][Full Text] [Related]
19. Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
Becattini C; Cimini LA; Carrier M
Thromb Res; 2021 Apr; 200():41-47. PubMed ID: 33529872
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation Resumption After Intracerebral Hemorrhage.
Li YG; Lip GYH
Curr Atheroscler Rep; 2018 May; 20(7):32. PubMed ID: 29781063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
